
RSV Phase 3 Prepare™ Trial Outcome De-risked by Successful Informational AnalysisNanoFlu™ Vaccine Demonstrates Improved ...

CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI® [VONICOG ALFA, RECOMBINANT VON WILLEBRAND FACTOR] FOR ...

Dublin, Dec. 16, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...
Click to continue to site. Closing